Private company
Cue Health Inc.
In its 2024 annual report the company says: “We are a health technology company, and our mission is to empower people to live their healthiest lives. We are helping pioneer this healthcare digital transformation, beginning with diagnostics. We started from consumer-centric principles and designed our proprietary platform, the Cue Integrated Care Platform, with a relentless focus on user experience, convenience, and accuracy, with the goal of enabling people to make quicker, better-informed healthcare decisions.”4 It is headquartered in San Diego, California.1
Last updated Oct 20, 2026.
Overview
- IndustryLaboratory Analytical Instruments1
- HeadquartersSan Diego, California1
- Business address4980 Carroll Canyon Road, Suite 100, San Diego, Ca 921212
- Filer category, Emerging growth company2
See how the biggest companies compare on our leaderboards
We are a health technology company, and our mission is to empower people to live their healthiest lives. Digital transformation has revolutionized nearly every industry to create new, consumer-first experiences that are both personalized and empowering. We seek to usher in a new era in healthcare, what we call Healthcare 2.0, to transform how acute and chronic conditions are diagnosed and managed.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Research and development96¢$150.6M
- Interest1¢$1.2M
- Income tax3¢$4.8M
Out of $70.9M in revenue.5 The company lost money this year.
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenue | $6.6M6 | $23.0M7 | $618.1M5 | $483.5M5 | $70.9M5 | |
| Research and development | $21.4M6 | $28.5M7 | $42.8M5 | $171.5M5 | $150.6M5 | |
| Operating income | -$20.8M6 | -$45.1M7 | $190.2M5 | -$205.7M5 | -$394.9M5 | |
| Interest | $9.8M5 | $645.0K5 | $1.2M5 | |||
| Income before tax | $119.2M5 | -$203.8M5 | -$368.7M5 | |||
| Income tax | $06 | $07 | $32.8M5 | -$9.7M5 | $4.8M5 | |
| Net income | -$20.6M6 | -$47.4M7 | $86.4M5 | -$194.1M5 | -$373.5M5 | |
| Earnings per share | -$1.316 | -$2.907 | $0.635 | -$1.315 | -$2.445 | |
| Earnings per share (diluted) | -$1.316 | -$2.907 | $0.595 | -$1.315 | -$2.445 | |
| Shares (weighted, basic) | 52.8M shares5 | 148.0M shares5 | 152.9M shares5 | |||
| Shares (weighted, diluted) | 59.6M shares5 | 148.0M shares5 | 152.9M shares5 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Cash | $26.8M6 | $14.3M6 | $121.6M7 | $409.9M5 | $241.5M5 | $80.9M5 |
| Receivables | $104.6M7 | $18.8M5 | $1.4M5 | |||
| Inventory | $88.4M7 | $82.2M5 | $14.0M5 | |||
| Current assets | $183.7M6 | $670.0M7 | $371.2M5 | $110.4M5 | ||
| Intangible assets | $7.7M7 | $16.9M5 | $19.6M5 | |||
| Total assets | $316.3M6 | $940.1M7 | $694.6M5 | $339.8M5 | ||
| Accounts payable | $37.2M7 | $7.2M5 | $7.7M5 | |||
| Short-term debt | $06 | |||||
| Current liabilities | $155.9M6 | $166.9M7 | $71.2M5 | $43.5M5 | ||
| Total liabilities | $241.4M6 | $233.3M7 | $118.1M5 | $89.5M5 | ||
| Retained earnings | -$24.0M7 | -$218.1M5 | -$591.5M5 | |||
| Shareholders’ equity | -$37.9M6 | -$58.1M7 | -$101.4M5 | $706.8M5 | $576.5M5 | $250.3M5 |
| Shares outstanding | 28.0M shares6 | 146.4M shares7 | 150.4M shares5 | 155.3M shares5 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Cash from operations | -$13.0M6 | $92.7M7 | -$9.4M5 | -$111.9M5 | -$137.8M5 | |
| Depreciation and amortization | $32.8M5 | $49.0M5 | $56.3M5 | |||
| Stock-based compensation | $43.0M5 | $64.3M5 | $48.7M5 | |||
| Capital spending | $2.9M6 | $76.0M7 | $108.8M5 | $50.2M5 | $9.2M5 | |
| Free cash flow | -$15.9M | $16.6M | -$118.3M | -$162.1M | -$147.0M | |
| Cash from investing | -$115.7M5 | -$63.0M5 | -$19.8M5 | |||
| Cash from financing | $419.6M5 | -$6.4M5 | -$3.0M5 |
Corporate structure
Cue Health Inc. sits at the top of its group. 5 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Cue Health Inc.
- Tarsadia Capital, LLC Filed SC 13D/A on Cue Health Inc., latest Aug 27, 2024 (5 filings since Sep 11, 2023)
- Ayub K. Khattak Filed SC 13G/A on Cue Health Inc., latest Feb 14, 2024 (3 filings since Feb 14, 2022)
- KSP Cue Health Investments, LLC Filed SC 13G/A on Cue Health Inc., latest Feb 9, 2024 (3 filings since Feb 9, 2022)
- OAKMONT Corp Filed SC 13D on Cue Health Inc., latest Oct 16, 2023 (3 filings since Feb 14, 2022)
- Decheng Capital Management III (Cayman), LLC Filed SC 13G on Cue Health Inc., latest Feb 14, 2022
- Sherpa Ventures Fund, LP Filed SC 13G on Cue Health Inc., latest Feb 14, 2022
- KOCH INDUSTRIES LLC Filed SC 13G on Cue Health Inc., latest Oct 8, 2021
- Cue Health Inc. San Diego, California
- CHP HC, LLC Subsidiary · Delaware, United States
- Cue Health India Private Limited Subsidiary · India
- Cue Health Sağlik Yazilimi Hizmetleri Limited Şirketi Subsidiary · Turkey
- TrustedMedRx, LLC Subsidiary · Florida, United States
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Cue Health Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Computer equipment and software | $19.1M7 Dec 31, 2022 | $5.6M7 Dec 31, 2021 | +237.9% |
| Finance-lease assets | $4.8M5 Dec 31, 2023 | $7.3M5 Dec 31, 2022 | −33.3% |
| Operating-lease assets (leased space) | $78.5M5 Dec 31, 2023 | $85.3M5 Dec 31, 2022 | −8.0% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $80.9M5 Dec 31, 2023 | $241.5M5 Dec 31, 2022 | −66.5% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Intangible assets, net (excluding goodwill) | $19.6M5 Dec 31, 2023 | $16.9M5 Dec 31, 2022 | +16.5% |
| Accumulated amortization | $13.6M5 Dec 31, 2023 | $5.7M5 Dec 31, 2022 | +138.4% |
| Finite-lived intangibles, net | $19.6M5 Dec 31, 2023 | $16.9M5 Dec 31, 2022 | +16.5% |
Inventory
Leadership
Who has led Cue Health Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerClint Sever Mar 27, 2024 to Mar 27, 202411
- Chief executive officerAyub K. Khattak Sep 23, 2021 to Mar 7, 202412
- PresidentAyub K. Khattak Sep 23, 2021 to Mar 7, 202412
- Chief financial officerAasim Javed Mar 27, 2023 to May 21, 202413
- Chief financial officerJohn E. Gallagher Sep 23, 2021 to Mar 6, 202314
Board members and other officers (14)
- Chief Accounting OfficerRandall E. Pollard Mar 6, 2023 to Mar 7, 202415
- Chief Strategy OfficerChristopher K. Achar Sep 23, 2021 to Sep 23, 202116
- Chief Product OfficerClint Sever Sep 23, 2021 to Mar 7, 202417
- Board memberRishi Reddy Feb 27, 2024 to Feb 27, 202418
- Board memberJoshua Ghaim Aug 4, 2022 to Jun 7, 202319
- Board memberSachin H. Jain Oct 11, 2022 to Jun 7, 202320
- Board memberAyub K. Khattak Sep 23, 2021 to Mar 7, 202412
- Board memberCarole T. Faig Sep 23, 2021 to Jun 7, 202321
- Board memberChristopher K. Achar Sep 23, 2021 to Mar 7, 202416
- Board memberK. Joanne Bradford Sep 23, 2021 to Jun 7, 202322
- Board memberMaria Martinez Sep 23, 2021 to Jun 7, 202323
- Board memberScott Stanford Sep 23, 2021 to Sep 30, 202124
- Board memberXiangmin Cui Sep 23, 2021 to Sep 30, 202125
- General counselErica Palsis Sep 23, 2021 to Dec 7, 202326
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- CHP HC, LLC Delaware3
- Cue Health India Private Limited India3
- Cue Health Sağlik Yazilimi Hizmetleri Limited Şirketi Turkey3
- TrustedMedRx, LLC Florida3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- Cue Inc.Dec 29, 2014 to May 16, 20172
Timeline
- May 28, 20248-K Ended a material agreement; Bankruptcy or receivership; Listing notice or transfer27
- May 16, 20248-K Executive or director change; Shareholder vote; Other events28
- May 1, 20248-K Exit or restructuring costs29
- Apr 24, 20248-K Executive or director change30
- Apr 9, 20248-K Entered a material agreement; Change to shareholders' rights; Other events31
- Mar 29, 20248-K Executive or director change32
- Mar 27, 2024New chief executive Clint Sever becomes CEO11
- Mar 20, 20248-K Executive or director change33
- Mar 13, 20248-K Results of operations34
- Feb 16, 20248-K Entered a material agreement; Executive or director change35
- Jan 25, 20248-K Exit or restructuring costs36
- Jan 5, 20248-K Exit or restructuring costs; Other events37
- Nov 8, 20238-K Results of operations38
- Sep 23, 2021New chief executive Ayub K. Khattak becomes CEO12
Calendar
When it reported results
- Mar 13, 2024Reported quarterly or annual results34
- Nov 8, 2023Reported quarterly or annual results38
- Aug 9, 2023Reported quarterly or annual results39
- May 10, 2023Reported quarterly or annual results40
- Mar 15, 2023Reported quarterly or annual results41
- Nov 9, 2022Reported quarterly or annual results42
- Aug 10, 2022Reported quarterly or annual results43
- May 11, 2022Reported quarterly or annual results44
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
199 filings to the SEC since October 2021: 4 annual reports, 7 quarterly reports, 39 major events, 114 insider forms, 17 large holders, 18 other. The latest 20:
- Aug 27, 2024SC 13D/A CUE HEALTH INC. EDGAR
- Aug 27, 20244 EDGAR
- May 28, 20248-K EDGAR
- May 21, 20244/A EDGAR
- May 17, 2024SC 13D/A EDGAR
- May 16, 20248-K EDGAR
- May 16, 2024NT 10-Q EDGAR
- May 1, 20248-K EDGAR
- Apr 24, 20248-K EDGAR
- Apr 22, 2024ARS EDGAR
- Apr 22, 2024DEF 14A EDGAR
- Apr 12, 2024PRE 14A EDGAR
- Apr 9, 20248-K EDGAR
- Apr 9, 20248-A12B/A EDGAR
- Mar 29, 20248-K EDGAR
- Mar 27, 20244 EDGAR
- Mar 20, 20248-K EDGAR
- Mar 13, 2024S-8 EDGAR
- Mar 13, 202410-K EDGAR
- Mar 13, 20248-K EDGAR
The 199 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
37 open-market trades by officers, directors and large owners since October 2021: 0 buys and 37 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 27, 2024 | TFC Manager, LLC10% owner | Sale | 3,319,000 | Form 4 | ||
| Aug 23, 2024 | TFC Manager, LLC10% owner | Sale | 14,983,244 | Form 4 | ||
| Dec 8, 2022 | Sever ClintChief Executive Officer | Sale | 29,269 | $3.02 | $88.4K | Form 4 |
| Dec 7, 2022 | Sever ClintChief Executive Officer | Sale | 24,147 | $2.98 | $72.0K | Form 4 |
| Dec 6, 2022 | Sever ClintChief Executive Officer | Sale | 26,664 | $3.14 | $83.7K | Form 4 |
| Nov 30, 2022 | Sever ClintChief Executive Officer | Sale | 22,725 | $3.11 | $70.7K | Form 4 |
| Nov 25, 2022 | Sever ClintChief Executive Officer | Sale | 19,089 | $2.48 | $47.3K | Form 4 |
| Nov 23, 2022 | Sever ClintChief Executive Officer | Sale | 19,089 | $2.58 | $49.2K | Form 4 |
| Nov 22, 2022 | Sever ClintChief Executive Officer | Sale | 19,089 | $2.56 | $48.9K | Form 4 |
| Nov 10, 2022 | Sever ClintChief Executive Officer | Sale | 26,664 | $3.94 | $105.1K | Form 4 |
| Nov 9, 2022 | Sever ClintChief Executive Officer | Sale | 26,664 | $3.73 | $99.5K | Form 4 |
| Nov 8, 2022 | Sever ClintChief Executive Officer | Sale | 26,664 | $3.81 | $101.6K | Form 4 |
| Oct 27, 2022 | Sever ClintChief Executive Officer | Sale | 26,664 | $3.63 | $96.8K | Form 4 |
| Oct 26, 2022 | Sever ClintChief Executive Officer | Sale | 26,664 | $3.70 | $98.7K | Form 4 |
| Oct 25, 2022 | Sever ClintChief Executive Officer | Sale | 26,664 | $3.51 | $93.6K | Form 4 |
| Oct 13, 2022 | Sever ClintChief Executive Officer | Sale | 26,664 | $3.30 | $88.0K | Form 4 |
| Oct 12, 2022 | Sever ClintChief Executive Officer | Sale | 26,664 | $3.24 | $86.4K | Form 4 |
| Oct 11, 2022 | Sever ClintChief Executive Officer | Sale | 26,664 | $3.32 | $88.5K | Form 4 |
| Sep 30, 2022 | Sever ClintChief Executive Officer | Sale | 7,374 | $3.03 | $22.3K | Form 4 |
| Sep 29, 2022 | Sever ClintChief Executive Officer | Sale | 19,290 | $2.94 | $56.7K | Form 4 |
All 37 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Tarsadia Capital, LLCSC 13D/A, 5 filings Sep 11, 2023 to Aug 27, 202445
- Ayub K. KhattakSC 13G/A, 3 filings Feb 14, 2022 to Feb 14, 202446
- KSP Cue Health Investments, LLCSC 13G/A, 3 filings Feb 9, 2022 to Feb 9, 202447
- OAKMONT CorpSC 13D, 3 filings Feb 14, 2022 to Oct 16, 202348
- Decheng Capital Management III (Cayman), LLCSC 13G, 1 filing Feb 14, 202249
- Sherpa Ventures Fund, LPSC 13G, 1 filing Feb 14, 202250
- KOCH INDUSTRIES LLCSC 13G, 1 filing Oct 8, 202151
SEC filer profile
How Cue Health Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARCue Health Inc.1
- CIK0001628945
- Employer ID (EIN)27-15621931
- Filer status<br>emerging growth company1
- Fiscal year endsDecember 311
- Industry code (SIC)3826 Laboratory Analytical Instruments1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address4980 Carroll Canyon Road, Suite 100, San Diego, CA 921211
- Phone(858) 412-81511
- Shares outstanding158,516,303 as of Mar 4, 20245
- Public float$50.0M as of Jun 30, 20235
- On EDGAR sinceDec 29, 20141
- Filings255 in all: 4 (119), 8-K (39), 3 (20), 10-Q (7), CORRESP (6), SC 13G/A (6), SC 13G (5), UPLOAD (5)1
All 35 form types
S-8 (4), SC 13D/A (4), 10-K (3), D (3), DEF 14A (3), 4/A (2), 8-A12B (2), ARS (2), DRS/A (2), DRSLTR (2), EFFECT (2), S-1/A (2), SC 13D (2), SEC STAFF LETTER (2), 10-K/A (1), 25-NSE (1), 424B4 (1), 424B5 (1), 8-A12B/A (1), 8-K/A (1), CERT (1), DRS (1), NT 10-Q (1), PRE 14A (1), S-1 (1), S-3 (1), S-3/A (1)
- Latest filingsAnnual report (10-K) Mar 13, 2024
Quarterly report (10-Q) Nov 8, 2023
Proxy statement (DEF 14A) Apr 22, 2024
Latest 8-K (8-K) May 28, 2024
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCue Health Inc. filings on SEC EDGAR
- 2SEC EDGARCue Health Inc. filings on SEC EDGAR
- 3
- 4
- 5SEC EDGARCue Health Inc. 10-K for fiscal 2023
- 6SEC EDGARCue Health Inc. 10-K for fiscal 2019
- 7SEC EDGARCue Health Inc. 10-K for fiscal 2020
- 8SEC EDGARCue Health Inc. 10-Q for fiscal 2023
- 9SEC EDGARCue Health Inc. 10-Q for fiscal 2023
- 10SEC EDGARCue Health Inc. 10-Q for fiscal 2023
- 11SEC EDGARClint Sever, Chief executive officer
- 12
- 13SEC EDGARAasim Javed, Chief financial officer
- 14
- 15
- 16
- 17SEC EDGARClint Sever, Chief Product Officer
- 18SEC EDGARRishi Reddy, Board member
- 19SEC EDGARJoshua Ghaim, Board member
- 20SEC EDGARSachin H. Jain, Board member
- 21SEC EDGARCarole T. Faig, Board member
- 22SEC EDGARK. Joanne Bradford, Board member
- 23SEC EDGARMaria Martinez, Board member
- 24SEC EDGARScott Stanford, Board member
- 25SEC EDGARXiangmin Cui, Board member
- 26SEC EDGARErica Palsis, General counsel
- 27
- 28
- 29SEC EDGARExit or restructuring costs
- 30SEC EDGARExecutive or director change
- 31
- 32SEC EDGARExecutive or director change
- 33SEC EDGARExecutive or director change
- 34SEC EDGARResults of operations
- 35
- 36SEC EDGARExit or restructuring costs
- 37
- 38SEC EDGARResults of operations
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51